New Trends in Pharmacology & Drug Development

Aurora kinases control multiple events during cell cycle progression and are essential for mitotic and meiotic bipolar spindle assembly and function. There are three aurora kinases in mammals, some of which have oncogenic properties and all of which are overexpressed in multiple cancers 2.The kinetics of drug binding to gpcrs are complex and depend on several factors, including charge distribution on the receptor surface, ligand–receptor interactions in the binding channel and the binding site, or solvation. Previously, drugs were developed focusing on target affinity and selectivity. However, it is becoming evident that the drug–target residence time, related to the off-rate, is an important parameter for successful drug development. The residence time influences both the on-rate and overall effectiveness of drugs. Due to recent efforts in the development of fast computers, md simulations and related techniques allow calculation of the binding pathways of ligands and estimation of rate constants 3. Protease-activated receptors (pars) are a ubiquitously expressed class of g-protein-coupled receptors (gpcrs) that enable cells to respond to proteases in the extracellular environment in a nuanced and dynamic manner. Two agents targeting par1, recombinant activated protein c and vorapaxar, are US FDA approved. However, their use has been limited by questions of efficacy and safety, respectively.
 

  • Binding kinetics and pathways of ligands to GPCRs
  • Aurora A kinase ,a priority pharmaceutical target for treatment of cancer
  • Novel adjuvants designed for improving vaccine efficacy
  • Targetting Protease-activated receptors(PAR1)
  • Risks associated with new drug development

Related Conference of New Trends in Pharmacology & Drug Development

March 01 - 03, 2018

4th European Organic Chemistry Congress

London,UK
Oct 17-18, 2018

Chromatographic Separation Techniques

Toronto
May 18-19, 2018

11th Global Experts Meeting on Chemistry

Singapore
July 23-24, 2018 Lisbon, Portugal

9th Global Chemistry Congress

June 25-27, 2018

4th International Conference on Polymer Chemistry

Stockholm, Sweden
August 29-30, 2018

18th International Conference on Analytical Chemistry

Toronto, Canada
July 18-19 , 2018

24th International Conference onOrganic & Inorganic Chemistry

Atlanta, Georgia, USA
July 25-26, 2018

20th International Conference on Medicinal Chemistry & Pharmacology

Vancouver, British Columbia, Canada

8th European Chemistry Congress

June 21-23, 2018 Paris, France
August 27-28, 2018

3rd International Conference and Exhibition on Polymer Chemistry

Toronto, Ontario, Canada
September 06-07, 2018

International Conference on Polymerization Catalysis

| Dubai, UAE
September 12-13, 2018

11th Annual Congress on Chemistry

Singapore
September 13-14, 2018

9th International Conference and Expo on Separation Techniques

Zurich, Switzerland
September 17-19, 2018

9th World Congress on Green Chemistry and Technology

Amsterdam, Netherlands
September 24-25, 2018

32nd International Conference on Drug Chemistry

Chicago, Illinois, USA
October 03-04 , 2018

24th World Chemistry & Systems Biology Conference

Los Angeles, California, USA
October 29-31, 2018

3rd International Conference on Pharmaceutical Chemistry

Brussels, Belgium
Oct 31- Nov01, 2018

34th International Conference on Pharmaceutical Chemistry

San Francisco, California, USA
October 31- November 01, 2018

International Conference on Analytical and Bio analytical Techniques

Columbus, Ohio, USA
November 05-06, 2018

International Conference on Catalysis and Pyrolysis 2018
(ICCP-2018)


(10 Plenary Forums - 1Event)
San Francisco, USA
Dec 05-06, 2018

28th International conference onChemistry & Drug Discovery 2018

Vancouver, British Columbia, Canada

New Trends in Pharmacology & Drug Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in